
Israel-Related Stocks Decline Globally After Hamas Shock Attacks
The surprise attack on Israel by Hamas weighed on shares of global companies with local connections, including chipmakers
2023-10-09 18:58

Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
2023-10-09 09:20

Sanofi Is Exploring Acquisition of Cancer Drugmaker Mirati
French pharmaceutical firm Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people
2023-10-06 17:51

Traders Win Reprieve After ‘Political Circus’ of Shutdown Fight
An against-the-odds deal to avert a US shutdown is soothing nerves across Wall Street after a week of
2023-10-02 07:50

Nestle Divests Peanut-Allergy Drug on Disappointing Uptake
Nestle SA sold its peanut-allergy medicine business to Swiss health-care group Stallergenes Greer after the food company gave
2023-09-04 14:55

Fed Latest: China Still Embedded in US Supply Chain, Paper Finds
China remains embedded in US supply chains even as American firms have taken steps to reduce direct imports
2023-08-26 22:58

China Looks to Attract Foreign Investment as Its Economy Struggles
China’s latest attempt to reverse the nation’s foreign investment slump includes pledges to offer overseas firms better tax
2023-08-14 15:22

China Ending Years-Long Crackdown Restores Optimism as Tech Giants Report
China wrapping up its crackdown on tech firms and switching to supporting the industry sets the tone as
2023-08-14 11:20

Biotech Firm Vistagen Surges 1,370% on Social Anxiety Spray Trial Success
A beaten down micro-cap biotech company, Vistagen Therapeutics Inc., notched its best day ever, surging by as many
2023-08-08 04:15

Sage Tumbles as Depression Pill Approval Omits Major Disorder
Sage Therapeutics Inc. slumped in early trading after regulators granted approval to its fast-acting pill only for postpartum
2023-08-07 20:15

Rakuten’s Mikitani Spends a Fifth of His Time on Biotech Startup
Hiroshi Mikitani, whose Rakuten Group Inc. is losing billions of dollars to break into Japan’s wireless market, said
2023-08-07 05:58

Astellas Pharma Secures US FDA Approval for Izervay
The US Food and Drug Administration approved Astellas Pharma Inc.’s Izervay for the treatment of age-related macular degeneration,
2023-08-05 10:54